Commonwealth Equity Services’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
ACM
CAM
HP
MIF
SOADOR
LSERS
BCM
Commonwealth Equity Services's KRYS Position: Q2 2026 in Review
Commonwealth Equity Services increased its Krystal Biotech (KRYS) stake by 4.5% in Q2 2026, buying an estimated $157K and bringing the position to 12,116 shares worth $4.5M. The position accounts for 0.01% of the portfolio, ranked #1483.
Commonwealth Equity Services first reported a position in KRYS in Q1 2022 and has held it in 18 quarters since. 104 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- Commonwealth Equity Services held 12,116 shares of Krystal Biotech worth $4.5M as of Q2 2026.
- Commonwealth Equity Services bought 525 Krystal Biotech shares in Q2 2026, an estimated $157K.
- Krystal Biotech made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1483 holding.
- Commonwealth Equity Services first reported a position in Krystal Biotech in Q1 2022 and has held it in 18 quarters since.
- 104 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.